Quince Therapeutics doses first subject in Ataxia-Telangiectasia trial

ChromaDex wins orphan designation for rare ataxia drug

Nanopore Long-Read Sequencing Facilitates Diagnosis of Atypical Ataxia-Telangiectasia

IBEC and AEFAT join forces against ataxia telangiectasia

Organoids to study ataxia telangiectasia

Boston Children's Hospital lab trying to develop drug to treat boy's deadly rare disease

U.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasia

Governor of Queensland Celebrates Ataxia Telangiectasia Clinical Trial

Acasti reports results from ataxia telangiectasia therapy trial

A New Model for Neurodegenerative Disease